European Union offers `immediate aid` to help India out of Covid crisis

European Union offers `immediate aid` to help India out of Covid crisis

According to media reports, the AstraZeneca vaccine developed by Oxford University was reported to have a 76 per cent effectiveness against symptomatic infections for three months after receiving the first dose and the percentage (of effectiveness) is expected to increase if the recipient is given a second dose.

Travel between the United States and Europe has been banned since March 2020, when the European Union leaders agreed to enforce travel restrictions for foreigners in a bid to contain the spread of the COVID-19, SchengenVisaIfo.com reports.

AstraZeneca's vaccine was initially expected to be the first to receive federal emergency authorization, and the US government ordered enough for 150 million Americans before issues with the vaccine's clinical trial held up clearance.

The EU Commission added: "Some terms of the contract have not been respected and the company has not been in a position to come up with a reliable strategy to ensure a timely delivery of doses".

A Commission spokesperson told the Monday news conference "The Commission has been taking legal action against AstraZeneca since Friday", adding that all 27 European Union member states supported the decision. USA citizens and permanent residents are exempt from the measures.

"Our company is about to deliver nearly 50 million doses to European countries by the end of April, in line with our forecast", AstraZeneca said in a statement.

Police Shoot Black Teenager Ma'Khia Bryant In Columbus, Ohio
WBNS-TV reported that the girl shot by police was 16-year-old Ma'Khia Bryant, according to the girl's mother, Paula Bryant. According to The Columbus Dispatch it was at 4:35 PM EST when 911 received a call about an "attempted stabbing".

Decisions from drug regulators in several European nations to delay advising the shot for older adults, because of a lack of trial data in those age groups, may have contributed to hesitancy in taking the vaccine in parts of the continent.

In a surprising move, however, the United Kingdom drug regulatory body said that it would offer people under 30 the choice of another product and it stopped the ongoing trials of the vaccine on teenagers.

It has since stated that its option for extra AstraZeneca doses will not be taken up.

However, the body placed no new age restrictions on using the vaccine in people 18 and over, as some countries have done. It said most of the cases reported have occurred in women under 60, and within two weeks of vaccination.

Dr. June Raine, the head of Britain's Medicines and Healthcare Products Regulatory Agency, agreed with the EMA finding, saying that, in her opinion, the benefits "continue to outweigh the risks for the vast majority of people".

"What matters to us in this case is that we want to make sure there is a speedy delivery of a sufficient number of doses that European citizens are entitled to", Stefan De Keersmaecker, the European Commission's spokesperson for health, food safety and transport, said at a press conference. "This will allow them to travel and move freely", said the President.

Related Articles